YBX1 and breast cancer: The results of the ActD rescue experiment showed that CDK1 mRNA stability was reduced in breast cancer cells following CD2BP2‐DT knockdown, and this reduction was partially reversed by YBX1 overexpression in the context of CD2BP2‐DT knockdown.